AVRICORE HEALTH INC.

Avricore Health (TSX-V:AVCR, OTC:AVCRF) said it in the first half of 2023 it continues to surpass financial targets, strike partnerships, and develop new markets as it brings its turkey solution for point-of-care testing HealthTab to additional pharmacies across Canada and internationally. The company noted that its first-half earnings were up 437% at $1,177,290 compared to the same period last year with more HealthTab systems deployed and tets sold. » Mehr auf proactiveinvestors.com

Avricore Health (TSX-V:AVCR, OTC:AVCRF) Inc has announced the signing of a reseller agreement between HealthTab Inc, the company's point-of-care testing solution, and Abbott Rapid Dx UK & Ireland.  The pharmacy service innovator said the agreement provides a foundation for HealthTab to purchase and distribute the Afinion 2 and associated tests for diabetes and heart disease screening in community pharmacies in the UK. » Mehr auf proactiveinvestors.com

Avricore Health (TSX-V:AVCR, OTC:AVCRF) announced that it has partnered with Ascensia Diabetes Care to integrate its blood glucose monitoring systems with Avricore's pharmacy-based point-of-care testing platform HealthTab. Avricore said the objective of the partnership is to support patients and pharmacists in Canada to better manage diabetes by linking daily blood glucose testing results and pattern history data collected via Ascensia's CONTOUR NEXT GEN or CONTOUR NEXT ONE meters to the patient's HealthTab account. » Mehr auf proactiveinvestors.com